Evelien P Mauser-Bunschoten Selected Research

von Willebrand Diseases (von Willebrand's Disease)

11/2020	ADAMTS-13 and bleeding phenotype in von Willebrand disease.
1/2019	Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
1/2018	Circulating Angiogenic Mediators in Patients with Moderate and Severe von Willebrand Disease: A Multicentre Cross-Sectional Study.
12/2015	Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
1/2014	[Von Willebrand disease in the Netherlands: the WiN study].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Evelien P Mauser-Bunschoten Research Topics

Disease

10	Hemorrhage 01/2023 - 12/2004
8	Hemophilia A (Haemophilia) 01/2019 - 01/2002
5	von Willebrand Diseases (von Willebrand's Disease) 11/2020 - 01/2014
1	Infections 01/2023
1	Vascular Malformations 01/2018
1	Type 3 von Willebrand Disease 01/2018
1	Thromboembolism 01/2018
1	Hemophilia B (Haemophilia B) 05/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2009
1	Acute Coronary Syndrome 12/2009
1	Atrial Fibrillation 12/2009
1	HIV Infections (HIV Infection) 12/2004
1	Hepatitis C 12/2004

Drug/Important Bio-Agent (IBA)

6	Factor VIII (Coagulation Factor VIII)IBA 01/2019 - 12/2004
4	Blood Coagulation Factors (Coagulation Factor)IBA 01/2019 - 12/2009
3	von Willebrand FactorIBA 11/2020 - 01/2014
3	Tranexamic Acid (AMCA)FDA Link 01/2019 - 12/2015
3	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2019 - 12/2015
3	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2019 - 12/2015
3	Aminocaproic Acid (6 Aminocaproic Acid)FDA LinkGeneric 01/2019 - 12/2015
3	AntibodiesIBA 08/2008 - 01/2002
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2019 - 12/2015
1	InterferonsIBA 01/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 01/2019
1	Vitamin K FDA Link 01/2018
1	AnticoagulantsIBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	nonacog beta pegolIBA 05/2016
1	Immunoglobulin G (IgG)IBA 08/2008
1	recombinant FVIIa (rFVIIa)FDA Link 01/2002
1	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 01/2002

Therapy/Procedure

6	Therapeutics 01/2019 - 12/2004
3	Oral Surgery (Maxillofacial Surgery) 01/2019 - 12/2015
1	Drug Tapering 01/2018
1	Operative Surgical Procedures 06/2012